| Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block] |
A summary of the exit and disposal costs recognized within Loss from Discontinued Operations in the consolidated statements of operations and comprehensive loss for the year ended December 31, 2011 are as follows:
|
|
|
|
|
|
For the Year Ended December 31, 2011 |
Non-cash charges |
|
Asset impairments (1) |
$ |
6,913 |
|
Cash charges |
|
|
Lease-related charges |
392 |
|
Severance charges |
1,120 |
|
Other charges |
(12 |
) |
Total charges |
$ |
8,413 |
|
|
|
(1) |
Asset impairments for the year ended December 31, 2011 represent the write-off of Pharmakon's goodwill and other intangible assets. |
The major classes of assets and liabilities included in the consolidated balance sheets for Pharmakon and TVG as of December 31, 2012 and December 31, 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2012 |
|
2011 |
Current assets |
$ |
14 |
|
|
$ |
1,013 |
|
Non-current assets |
150 |
|
|
625 |
|
Total assets |
$ |
164 |
|
|
$ |
1,638 |
|
Current liabilities |
$ |
368 |
|
|
$ |
1,865 |
|
Non-current liabilities |
1,006 |
|
|
1,526 |
|
Total liabilities |
$ |
1,374 |
|
|
$ |
3,391 |
|
The table below presents the significant components of Pharmakon's and TVG’s results included in Loss from Discontinued Operations in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2012 and 2011.
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
|
2012 |
|
2011 |
Revenue, net |
$ |
— |
|
|
$ |
5,880 |
|
|
|
|
|
Loss from discontinued operations, before income tax |
(51 |
) |
|
(8,374 |
) |
Income tax expense |
8 |
|
|
(237 |
) |
Loss from discontinued operations, net of tax |
$ |
(59 |
) |
|
$ |
(8,137 |
) |
A rollforward of the liabilities recognized in the consolidated balance sheet as of December 31, 2012 and December 31, 2011 is as follows:
|
|
|
|
|
Accrued liability as of January 1, 2011 |
$ |
16 |
|
Add: Costs incurred, excluding non-cash charges |
1,120 |
|
Less: Cash payments |
(16 |
) |
Accrued liability as of December 31, 2011 (1) |
$ |
1,120 |
|
Add: Costs incurred, excluding non-cash charges |
— |
|
Less: Cash payments |
(1,115 |
) |
Accrued liability as of December 31, 2012 (1) |
$ |
5 |
|
|
|
(1) |
Accrued liability at December 31, 2012 and 2011 consists of Pharmakon employee severance costs. |
|